PMC:7537941 / 30937-31088 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7537941","sourcedb":"PMC","sourceid":"7537941","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7537941","text":"PAR1 antagonism could therefore represent a potential approach to halt progression of the disease in hospitalised patients at risk of critical illness.","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T301","span":{"begin":42,"end":43},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"attributes":[{"subj":"T301","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PubTator","denotations":[{"id":"1006","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"1009","span":{"begin":114,"end":122},"obj":"Species"},{"id":"1020","span":{"begin":134,"end":150},"obj":"Disease"}],"attributes":[{"id":"A1006","pred":"tao:has_database_id","subj":"1006","obj":"Gene:2149"},{"id":"A1009","pred":"tao:has_database_id","subj":"1009","obj":"Tax:9606"},{"id":"A1020","pred":"tao:has_database_id","subj":"1020","obj":"MESH:D016638"},{"subj":"1006","pred":"source","obj":"LitCovid-PubTator"},{"subj":"1009","pred":"source","obj":"LitCovid-PubTator"},{"subj":"1020","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T167","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T167","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#d193ec","default":true},{"id":"LitCovid-PubTator","color":"#93ecb7"},{"id":"LitCovid-sentences","color":"#ec9d93"}]}]}}